Gordon D. Rubenfeld, M.D., Ellen Caldwell, M.S., Eve Peabody, B.A., Jim Weaver, R.R.T., Diane P. Martin, Ph.D., Margaret Neff, M.D., Eric J. Stern, M.D., and Leonard D. Hudson, M.D.
Background Acute lung injury is a critical illness syndromeconsisting of acute hypoxemic respiratory failure with bilateralpulmonary infiltrates that are not attributed to left atrialhypertension. Despite recent advances in our understanding ofthe mechanism and treatment of acute lung injury, its incidenceand outcomes in the United States have been unclear.
Methods We conducted a prospective, population-based, cohortstudy in 21 hospitals in and around King County, Washington,from April 1999 through July 2000, using a validated screeningprotocol to identify patients who met the consensus criteriafor acute lung injury.
Results A total of 1113 King County residents undergoing mechanicalventilation met the criteria for acute lung injury and were15 years of age or older. On the basis of this figure, the crudeincidence of acute lung injury was 78.9 per 100,000 person-yearsand the age-adjusted incidence was 86.2 per 100,000 person-years.The in-hospital mortality rate was 38.5 percent. The incidenceof acute lung injury increased with age from 16 per 100,000person-years for those 15 through 19 years of age to 306 per100,000 person-years for those 75 through 84 years of age. Mortalityincreased with age from 24 percent for patients 15 through 19years of age to 60 percent for patients 85 years of age or older(P<0.001). We estimate that each year in the United Statesthere are 190,600 cases of acute lung injury, which are associatedwith 74,500 deaths and 3.6 million hospital days.
Conclusions Acute lung injury has a substantial impact on publichealth, with an incidence in the United States that is considerablyhigher than previous reports have suggested.
Acute lung injury is a syndrome consisting of acute hypoxemicrespiratory failure with bilateral pulmonary infiltrates thatis associated with both pulmonary and nonpulmonary risk factorsand that is not primarily due to left atrial hypertension.1Despite recent advances in our understanding of the pathophysiology,treatment, and long-term outcome of acute lung injury, prospective,population-based data on the incidence and outcome of acutelung injury in the United States have not been available.2,3,4,5,6,7There has, however, been a prospective, population-based studyof patients with acute respiratory distress syndrome (ARDS),a subtype of acute lung injury characterized by more severehypoxemia.8 That study, which estimated the incidence of ARDSas 8.3 per 100,000 person-years, was performed in 6 of the 40hospitals in Utah in 1989, before the availability of currentdefinitions of acute lung injury.
On the basis of these and other data suggesting an incidenceof acute lung injury and ARDS of 1.5 to 8.3 per 100,000 person-years,these syndromes are considered rare.9,10 However, the studieson which these estimates are based were limited by several factors,including extrapolation from less than a complete year of observationor from a subgroup of the hospitals in a region, use of inaccurateadministrative coding, an absence of procedures to ensure reliablecase identification, use of obsolete definitions, and use ofobservations from countries where differences in the availabilityand utilization of intensive care services may limit the applicabilityof the data to the United States.11,12,13,14,15 The King CountyLung Injury Project (KCLIP) was designed to address some ofthe limitations of previous studies and to answer questionsabout the incidence and outcomes of acute lung injury and ARDS.
Methods
Study Design and Setting
We conducted a prospective cohort study to determine the incidenceand outcome of acute lung injury. The study was conducted in21 hospitals, which included all 18 hospitals in King County,Washington, that care for patients undergoing mechanical ventilation,as well as three hospitals in adjacent counties that also carefor this group of patients.
King County is the 12th most populous county in the United States,covering 5700 km2 (2200 mi2) and encompassing the urban areasaround Seattle and the surrounding rural areas. Because it isbounded on the west by water and on the east by mountains, itis unlikely that residents would seek health care outside thecounty. In comparison with the total U.S. population, the 1.74million persons living in King County in 2000 were wealthier(with a median annual family income of $53,000, as comparedwith $42,000 for the United States), were younger (with 10.5percent 65 years of age or older, as compared with 12.4 percentfor the United States), and had a different racial distribution(with 5.4 percent black and 10.8 percent Asian, as comparedwith 12.3 percent and 3.6 percent, respectively, for the UnitedStates).16 In 2000, the cause-specific mortality rates in KingCounty for diseases related to acute lung injury (pneumonia,trauma, and septicemia) were comparable to or lower than thosefor the United States as a whole.17 According to the WashingtonState Comprehensive Hospital Abstract Reporting System (CHARS)database, 96.4 percent of King County residents who underwentmechanical ventilation in Washington State in 2000 receivedtheir care at one of the 21 KCLIP study hospitals. Four of thesehospitals are primary teaching affiliates, where all criticallyill patients receive care from resident physicians; these areclassified as academic hospitals in the analysis. Data wereobtained from each hospital for 12 consecutive months duringthe period from April 1999 through July 2000.
Identification of Cases
Using data routinely obtained during clinical care of the patients,we identified patients with acute lung injury according to thedefinition of the AmericanEuropean Consensus Conferenceon ARDS.18 The criteria are the presence of acute hypoxemiawith a ratio of the partial pressure of arterial oxygen to thefraction of inspired oxygen (PaO2:FiO2) of 300 mm Hg or less(for acute lung injury) or of 200 mm Hg or less (for ARDS);bilateral infiltrates (including very mild infiltrates) seenon a frontal chest radiograph that are consistent with pulmonaryedema; and no clinical evidence of left atrial hypertensionor (if it is measured) a pulmonary-artery wedge pressure of18 mm Hg or less. If a patient had more than one episode thatmet the criteria, only the data from the first episode wereincluded in the study.
All patients who were undergoing mechanical ventilation in anintensive care unit (ICU) through either an endotracheal tubeor a face mask were screened for enrollment. To ensure thatpatients were not missed, we examined data from at least twosources at each hospital, including logs of patients undergoingmechanical ventilation, billing records, and other hospitaldatabases. Patient records were cross-checked among hospitalsto ensure that transferred patients were counted only once inthe study. Patients were excluded from the study if they werenot residents of King County (as determined by the ZIP Codeof their primary residence), if they were less than six monthsof age (to exclude patients with neonatal respiratory distresssyndrome), or if they had undergone mechanical ventilation forless than 24 hours after an operative procedure.
Only arterial blood gas measurements obtained while the patientwas intubated were assessed. The arterial blood gas values withthe worst PaO2:FiO2 ratio, regardless of the positive end-expiratorypressure, were used to assess oxygenation for each 24-hour period,and the values obtained on the first day on which the PaO2:FiO2ratio was 300 mm Hg or less and other criteria were met wereused to classify patients as having either acute lung injuryor ARDS. Because the PaO2:FiO2 ratio becomes an increasinglyunreliable assessment of shunt when the FiO2 is below 0.40,the ratio was used to assess oxygenation only when the FiO2was 0.40 or more.19
The study used a standardized protocol to identify patientswho met the enrollment criteria for acute lung injury. We usedrespiratory therapists and research nurses who had been trainedin the reliable identification of chest radiographs that metthe study criteria for acute lung injury and to collect dataon clinical risk factors for acute lung injury. Trained medical-recordabstractors collected other data from the medical records. Becauseour chest-radiography protocol was not designed to distinguishbetween chronic and acute abnormalities, radiographs showingbilateral parenchymal opacities in patients with a diagnosisof chronic pulmonary disease, such as asbestosis, pulmonaryfibrosis, lymphangitic carcinoma, and bronchiectasis, were setaside for separate analysis. To exclude pediatric patients,the analysis included only patients who were at least 15 yearsold. We chose this age cutoff on the basis of U.S. Census tables,which classify adolescents and young adults into age categoriesof 10 through 14, 15 through 19, and 20 through 24 years.
Patients were assessed for the presence of any risk factorsfor acute lung injury during the four days before the onsetof acute lung injury.20 These risk factors included severe sepsis,21which was divided into sepsis with a suspected pulmonary source(pneumonia) and sepsis with a suspected nonpulmonary sourceor an unidentified source; severe trauma (with an Injury SeverityScore22 above 15 [possible scores range from 0 to 75, with higherscores indicating more severe injury]); witnessed aspiration,transfusion of more than 15 units of blood within a 24-hourperiod, drug overdose, pancreatitis, near-drowning, and inhalationinjury. For this analysis, no attempt was made to assign a primaryrisk factor, and therefore the risk-factor categories are notmutually exclusive.
Patients with diagnoses of acute myocardial infarction or congestiveheart failure on admission to the ICU and with no identifiablerisk factors for acute lung injury were considered to have clinicalevidence of left atrial hypertension, as were patients witha pulmonary-artery wedge pressure greater than 18 mm Hg on alldays on which other criteria for acute lung injury were met(Figure 1).
Figure 1. The Study Cohort in the King County Lung Injury Project.
PaO2 denotes the partial pressure of arterial oxygen, FiO2 the fraction of inspired oxygen, and PAWP the pulmonary-artery wedge pressure.
Validation of Screening Protocol
Over a two-month period (from May 1 through June 30, 1999),we compared the results obtained by screening with the use ofour protocol with the results obtained by clinical screeningof 382 patients undergoing mechanical ventilation at HarborviewMedical Center.23 Each group of screeners was blinded to theresults obtained by the other group. After adjudication of discordantcases by two clinicians (an intensivist and a chest radiologist),who were also blinded to the results of case assignment by thetwo groups of screeners, our screening protocol had a kappavalue of 0.91 and an agreement of 96 percent with the adjudicateddiagnosis of acute lung injury.
Quality Control
Extensive efforts were made to ensure the quality of the datacollected throughout the study. At each site, the data froma randomly chosen 5 percent of screened patients and from allpatients about whom the screeners had questions were reviewedby the study physicians, including review of the chart and chestradiographs. Data from a random sample of 7 percent of caseswere abstracted and entered into the database twice, with anerror rate of less than 0.25 percent. The charts were reevaluateduntil the final notes, laboratory test results, and other resultswere complete. Complete data were available for 98.3 percentof the patients.
Statistical Analysis
The results are presented as percentages for categorical variablesand as medians with interquartile ranges or as means with standarddeviations for continuous variables. Depending on the distributionof the data, the Pearson chi-square test, the MannWhitneytest, or Student's t-test was used to compare groups. Ratesper 100,000 person-years were age-adjusted to the U.S. populationin 2000. Statistical analyses were performed with SAS software(version 9).
The study was approved by the University of Washington institutionalreview board and, when required, by the institutional reviewboards at the individual sites.
Results
During the study period, 6235 residents of King County underwentmechanical ventilation at the study hospitals, and 4251 werescreened for the study. Of these, 1687 eligible patients (40percent of the screened patients) met the criteria for acutehypoxemic respiratory failure and had a qualifying chest radiograph.Five hundred seventy-four of these 1687 patients (34 percent)had left atrial hypertension according to the clinical diagnosisor (when available) data from echocardiography or measurementof pulmonary-artery wedge pressure. The remaining 1113 patientsmet the criteria for acute lung injury, with an initial PaO2:FiO2of 300 mm Hg or less (Figure 1). Eight hundred twenty-eightof these (74 percent) had an initial PaO2:FiO2 of 200 mm Hgor less, meeting the criteria for ARDS, and 61 patients (21percent of the 285 patients with a PaO2:FiO2 greater than 200mm Hg and equal to or less than 300 mm Hg) progressed on eitherday 3 or day 7 of acute lung injury to a PaO2:FiO2 of 200 mmHg or less. According to these data, the incidence of acutelung injury in King County was 78.9 cases per 100,000 person-years,and the incidence of ARDS was 58.7 cases per 100,000 person-years.
The in-hospital mortality rate was 38.5 percent (95 percentconfidence interval, 34.9 to 42.2 percent) for patients withacute lung injury and 41.1 percent (95 percent confidence interval,36.7 to 45.4 percent) for those with ARDS. Patients who presentedwith a PaO2:FiO2 greater than 200 mm Hg and equal to or lessthan 300 mm Hg and who progressed on day 3 or day 7 to a PaO2:FiO2of 200 mm Hg or less had a mortality rate of 41.0 percent, similarto that of patients who presented with ARDS (P=0.5). Patientswho presented with a PaO2:FiO2 greater than 200 and equal toor less than 300, and who did not progress on day 3 or day 7to a PaO2:FiO2 of 200 or less, had a lower mortality rate (28.6percent) than did patients with ARDS (P=0.001).
The most common risk factor for acute lung injury was severesepsis with a suspected pulmonary source (46 percent), followedby severe sepsis with a suspected nonpulmonary source (33 percent).In this cohort, mortality varied according to the risk factorfrom 24.1 percent (95 percent confidence interval, 13.2 to 34.9percent) among patients with severe trauma, to 40.6 percent(95 percent confidence interval, 35.1 to 46.1 percent) amongpatients with severe sepsis with a suspected pulmonary source,to 43.6 percent (95 percent confidence interval, 31.9 to 55.2percent) among patients with witnessed aspiration. Extrapolatingthe age-adjusted incidence and mortality to the United Statespopulation leads to an estimate of 190,600 cases of acute lunginjury per year, with an associated 74,500 deaths and 2.2 milliondays in ICUs (Table 1). The incidence and mortality increasedwith age (Figure 2). The lowest age-specific incidence was inthose 15 through 19 years of age (16 cases per 100,000 person-years);the incidence increased with age to a peak of 306 cases per100,000 person-years in persons 75 through 84 years of age.Mortality also increased with age from a minimum of 24 percentamong those 15 through 19 years old to 60 percent among those85 years of age or older (P<0.001 for trend).
Figure 2. Age- and Risk-Specific Incidence of and Age-Specific Mortality from Acute Lung Injury.
Risk-factor categories are not mutually exclusive; P<0.001 for trend for the comparison of age-specific mortality rates.
The majority (59 percent) of patients with acute lung injurywere not cared for at one of the four academic sites where residentscare for all critically ill patients. As compared with patientsin the academic hospitals, patients in the community hospitalswere older, had a different racial distribution, had shorterlengths of stay in the ICU and in the hospital, had higher AcutePhysiology and Chronic Health Evaluation scores, had higherunadjusted in-hospital mortality rates, and had a differentdistribution of risk factors. Patients in the community hospitalsalso were more likely to be admitted from a nursing home orinstitution, less likely to be admitted by transfer from anotherhospital, and less likely to have recently undergone surgery(Table 2).
Table 2. Demographic Characteristics of Patients and Outcomes of Acute Lung Injury According to Hospital Type.
Discussion
Our data suggest that the incidence of acute lung injury inthe United States is between 2.5 and 5 times as high, and theincidence of ARDS is between 2 and 40 times as high, as previousstudies have indicated.10 According to these findings, 74,500persons die of acute lung injury in the United States each year,a figure that is comparable to the number of adult deaths attributedto breast cancer or human immunodeficiency virus disease in1999.6,24 It is equally important to note that more than 100,000patients survive acute lung injury each year, many of whom requirecare for cognitive abnormalities, weakness, depression, or post-traumaticstress disorder.2,25,26 In our study, only 34 percent of thesurvivors were well enough to be discharged directly home, afigure that probably reflects the fiscal pressures to shortenhospital stays and the degree of impairment after acute lunginjury. Because the risk of acute lung injury and the mortalityattributed to it increase with age, our results have importantimplications for the planning of services for critical care,mechanical ventilation, and rehabilitation in the future. Onthe basis of the age-specific incidence and mortality ratesthat we observed and projections of the future demographic characteristicsof the U.S. population, we estimate that in 25 years the annualincidence of acute lung injury will be 335,000 cases, with 147,000deaths per year.16
Several lines of reasoning support these results and suggestthat the incidence of acute lung injury in the United Stateshas been substantially underestimated in the past. By combiningrecent data on the incidence of severe sepsis and severe trauma(defined by Injury Severity Scores above 15) with data on theincidence of ARDS among patients with these conditions, theincidence of ARDS in the United States can be calculated as56 to 82 cases per 100,000 person-years.20,27,28,29,30 Anotherestimate, extrapolated from screening data from the ARDS Networkclinical trial, was based on the conservative assumption thatcases of acute lung injury are observed only in large ICUs withmore than 20 beds; according to this estimate, the incidenceof acute lung injury was 64.2 cases per 100,000 person-years.31Finally, it is of historical interest that an expert consensusin 1972 estimated that there were 150,000 cases of ARDS peryear in the United States,32 which is similar to the estimateswe project.
There are a number of important limitations to this study. First,the study was conducted in a single region in which the epidemiologyof acute lung injury may differ from that elsewhere in the UnitedStates. However, regional studies, most notably those from OlmstedCounty in Minnesota and Framingham, Massachusetts, have providedinvaluable epidemiologic data for many diseases.33,34 Childrenless than 15 years of age were excluded from this analysis,and therefore we cannot comment on the burden of pediatric acutelung injury.
The demographic features of King County are not identical tothose of the United States as a whole. Although we present anage-adjusted analysis, the numbers of patients of certain races(for example, black patients) were too small to allow us topresent reliable race-adjusted figures. The limited data thatare available suggest that the younger age, higher socioeconomicstatus, and unrepresentative racial distribution of King Countyresidents should bias our study toward underestimation of thetrue incidence of, and mortality from, acute lung injury inthe United States.35 Some of the differences between the academicand community sites may be explained by local differences incare procedures; for example, nearly all patients in the regionwith severe trauma are sent to an academic trauma center. Finally,patients may have been misclassified because of deficienciesin our protocol, missing documentation, or a lack of availableclinical tests. We tried to minimize the risk of misclassificationby validating the protocol against the results of clinical-trialscreening conducted at an institution with experience in theinvestigation of acute lung injury and by supplementing screeningwith extensive quality control, which included central reviewof cases and chest radiographs.
Our approach reflects current practice for enrolling patientsin clinical trials of acute lung injury; this practice doesnot require a specific diagnostic protocol to exclude clinicalevidence of left atrial hypertension or to establish the presenceof risk factors for acute lung injury. Recent studies suggestthat elevated left atrial pressure and acute lung injury frequentlycoexist, and therefore some misclassification may be unavoidableuntil better biomarkers of acute lung injury are developed.36Finally, with the notable exception of the incidence of acutelung injury, the cohort we studied is similar to other population-basedcohorts in studies of acute lung injury with regard to a numberof factors, a finding that supports the external validity ofour case-identification protocol (Table 3).
Table 3. Comparison of KCLIP Cohort with Other Population-Based Cohorts in Studies of Acute Lung Injury.
On the basis of our results, acute lung injury and ARDS occurwith a higher incidence than previously reported and thereforehave a substantial impact on public health in the United States.Data from population-based epidemiologic studies of criticalillnesses are essential for understanding the mechanism, trends,and burden of these diseases.
Supported by a grant from the National Institutes of Health(SCORHL30542), by the Firland Foundation, and by an unrestrictededucational grant from Advanced Lifeline Services.
We are indebted to the physicians, nurses, respiratory therapists,medical-records personnel, and administrative staff of the KingCounty Lung Injury Project hospitals, without whose hard workthis project would not have been possible: Auburn Regional MedicalCenter, Children's Hospital and Medical Center, Enumclaw CommunityMemorial Hospital, Evergreen Hospital Medical Center, GroupHealth Cooperative/Eastside, Harborview Medical Center, HighlineCommunity Hospital, Mary Bridge Children's Hospital, NorthwestHospital, Overlake Hospital Medical Center, Swedish MedicalCenterProvidence, St. Francis Hospital, St. Joseph Hospital,Stevens Health Care, Swedish Medical CenterBallard, SwedishMedical CenterFirst Hill, Tacoma General Hospital, Universityof Washington Medical Center, Valley Medical Center, VeteransAffairs Puget Sound Health Care System, and Virginia Mason MedicalCenter.
Source Information
From the Division of Pulmonary and Critical Care Medicine (G.D.R., E.C., E.P., J.W., M.N., L.D.H.) and the Department of Radiology (E.J.S.), Harborview Medical Center; and the Department of Health Services, School of Public Health and Community Medicine, University of Washington (D.P.M.) all in Seattle.
Address reprint requests to Dr. Rubenfeld at the Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Box 359762, 325 9th Ave., Seattle, WA 98104-2499, or at nodrog{at}u.washington.edu.
References
Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349. [Free Full Text]
Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-693. [Free Full Text]
The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308. [Free Full Text]
Amato MBP, Barbas CSV, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347-354. [Free Full Text]
Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-336. [Free Full Text]
Rubenfeld GD, Neff MJ. Epidemiology of acute lung injury: a public health perspective. In: Matthay MA, ed. Lung biology in health and disease. New York: Marcel Dekker, 2002:37-56.
Nuckton TJ, Alonso JA, Kallet RH, et al. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002;346:1281-1286. [Free Full Text]
Thomsen GE, Morris AH. Incidence of the adult respiratory distress syndrome in the state of Utah. Am J Respir Crit Care Med 1995;152:965-971. [Abstract]
National Organization for Rare Disorders home page. (Accessed September 23, 2005, at http://www.rarediseases.org.)
Garber BG, Hebert PC, Yelle JD, Hodder RV, McGowan J. Adult respiratory distress syndrome: a systemic overview of incidence and risk factors. Crit Care Med 1996;24:687-695. [CrossRef][ISI][Medline]
Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care 2004;8:222-226. [Medline]
Luhr OR, Antonsen K, Karlsson M, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 1999;159:1849-1861. [Free Full Text]
Bersten AD, Edibam C, Hunt T, Moran J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med 2002;165:443-448. [Free Full Text]
Hughes M, MacKirdy FN, Ross J, Norrie J, Grant IS. Acute respiratory distress syndrome: an audit of incidence and outcome in Scottish intensive care units. Anaesthesia 2003;58:838-845. [Medline]
Lewandowski K, Metz J, Deutschmann C, et al. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med 1995;151:1121-1125. [Abstract]
Centers for Disease Control and Prevention WONDER home page. (Accessed September 23, 2005, at http://wonder.cdc.gov.)
Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824. [Abstract]
Gowda MS, Klocke RA. Variability of indices of hypoxemia in adult respiratory distress syndrome. Crit Care Med 1997;25:41-45. [CrossRef][ISI][Medline]
Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301. [Abstract]
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-1655. [ISI][Medline]
Linn S. The injury severity score: importance and uses. Ann Epidemiol 1995;5:440-446. [CrossRef][Medline]
Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995;273:306-309. [Abstract]
Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep 2001;49:1-113. [Medline]
Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999;281:354-360. [Free Full Text]
Schelling G, Stoll C, Haller M, et al. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 1998;26:651-659. [CrossRef][ISI][Medline]
Nathens AB, Jurkovich GJ, MacKenzie EJ, Rivara FP. A resource-based assessment of trauma care in the United States. J Trauma 2004;56:173-178. [ISI][Medline]
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310. [CrossRef][ISI][Medline]
Rainer TH, Lam PK, Wong EM, Cocks RA. Derivation of a prediction rule for post-traumatic acute lung injury. Resuscitation 1999;42:187-196. [CrossRef][ISI][Medline]
Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997;336:912-918. [Free Full Text]
Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med 2003;31:1607-1611. [CrossRef][ISI][Medline]
National Heart and Lung Institute. Task force on problems, research approaches, needs: the lung program. Washington, D.C.: Department of Health, Education, and Welfare, 1972. (Publication no. (NIH) 73-432.)
Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7. [Free Full Text]
Griffin MR, Wilson WR, Edwards WD, O'Fallon WM, Kurland LT. Infective endocarditis: Olmsted County, Minnesota, 1950 through 1981. JAMA 1985;254:1199-1202. [Abstract]
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554. [Free Full Text]
Ferguson ND, Meade MO, Hallett DC, Stewart TE. High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome. Intensive Care Med 2002;28:1073-1077. [CrossRef][ISI][Medline]
Burnham, E. L., Halkar, R., Burks, M., Moss, M.
(2008). The Effects of Alcohol Abuse on Pulmonary Alveolar-Capillary Barrier Function in Humans. Alcohol Alcohol
0: agn051v1-agn051
[Abstract][Full Text]
Rubenfeld, G. D., Angus, D. C.
(2008). Are Intensivists Safe?. ANN INTERN MED
148: 877-879
[Full Text]
Parsons, P. E.
(2008). Genetics, Iron, and ALI: An Intriguing Relationship. Chest
133: 1295-1296
[Full Text]
Checkley, W., Brower, R., Korpak, A., Thompson, B. T., for the Acute Respiratory Distress Syndrome Networ,
(2008). Effects of a Clinical Trial on Mechanical Ventilation Practices in Patients with Acute Lung Injury. Am. J. Respir. Crit. Care Med.
177: 1215-1222
[Abstract][Full Text]
Adhikari, N. K J, Scales, D. C
(2008). Corticosteroids for acute respiratory distress syndrome. BMJ
336: 969-970
[Full Text]
Zambon, M., Vincent, J.-L.
(2008). Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time. Chest
133: 1120-1127
[Abstract][Full Text]
Davydow, D. S., Desai, S. V., Needham, D. M., Bienvenu, O. J.
(2008). Psychiatric Morbidity in Survivors of the Acute Respiratory Distress Syndrome: A Systematic Review. Psychosom. Med.
70: 512-519
[Abstract][Full Text]
Rubinson, L., Hick, J. L., Hanfling, D. G., Devereaux, A. V., Dichter, J. R., Christian, M. D., Talmor, D., Medina, J., Curtis, J. R., Geiling, J. A.
(2008). Definitive Care for the Critically Ill During a Disaster: A Framework for Optimizing Critical Care Surge Capacity: From a Task Force for Mass Critical Care Summit Meeting, January 26-27, 2007, Chicago, IL. Chest
133: 18S-31S
[Abstract][Full Text]
Boueiz, A., Damarla, M., Hassoun, P. M.
(2008). Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am. J. Physiol. Lung Cell. Mol. Physiol.
294: L830-L840
[Abstract][Full Text]
Imai, Y., Kuba, K., Penninger, J. M.
(2008). The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol
93: 543-548
[Abstract][Full Text]
Martin, T. R.
(2008). Interactions between Mechanical and Biological Processes in Acute Lung Injury. Proc Am Thorac Soc
5: 291-296
[Abstract][Full Text]
Matthay, M. A.
(2008). Treatment of Acute Lung Injury: Clinical and Experimental Studies. Proc Am Thorac Soc
5: 297-299
[Abstract][Full Text]
Kamp, R., Sun, X., Garcia, J. G. N.
(2008). Making Genomics Functional: Deciphering the Genetics of Acute Lung Injury. Proc Am Thorac Soc
5: 348-353
[Abstract][Full Text]
Tang, P. S., Mura, M., Seth, R., Liu, M.
(2008). Acute lung injury and cell death: how many ways can cells die?. Am. J. Physiol. Lung Cell. Mol. Physiol.
294: L632-L641
[Abstract][Full Text]
Rubinson, L., Christian, M. D.
(2008). Allocating Mechanical Ventilators During Mass Respiratory Failure: Kudos to New York State, but More Work to Be Done. dmphp
2: 7-10
[Full Text]
Matthay, M. A, Lee, J.
(2008). {beta}2 Adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury. Thorax
63: 189-190
[Full Text]
Liu, K. D., Matthay, M. A.
(2008). Advances in Critical Care for the Nephrologist: Acute Lung Injury/ARDS. CJASN
3: 578-586
[Abstract][Full Text]
Perkins, G D, Gao, F, Thickett, D R
(2008). In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax
63: 215-220
[Abstract][Full Text]
Meade, M. O., Cook, D. J., Guyatt, G. H., Slutsky, A. S., Arabi, Y. M., Cooper, D. J., Davies, A. R., Hand, L. E., Zhou, Q., Thabane, L., Austin, P., Lapinsky, S., Baxter, A., Russell, J., Skrobik, Y., Ronco, J. J., Stewart, T. E., for the Lung Open Ventilation Study Investigators,
(2008). Ventilation Strategy Using Low Tidal Volumes, Recruitment Maneuvers, and High Positive End-Expiratory Pressure for Acute Lung Injury and Acute Respiratory Distress Syndrome: A Randomized Controlled Trial. JAMA
299: 637-645
[Abstract][Full Text]
Frank, J A, Pittet, J-F, Wray, C, Matthay, M A
(2008). Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax
63: 147-153
[Abstract][Full Text]
Lagan, A. L., Melley, D. D., Evans, T. W., Quinlan, G. J.
(2008). Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization. Am. J. Physiol. Lung Cell. Mol. Physiol.
294: L161-L174
[Abstract][Full Text]
Bream-Rouwenhorst, H. R., Beltz, E. A., Ross, M. B., Moores, K. G.
(2008). Recent developments in the management of acute respiratory distress syndrome in adults. Am J Health Syst Pharm
65: 29-36
[Abstract][Full Text]
Prows, D. R., Hafertepen, A. P., Winterberg, A. V., Gibbons, W. J. Jr., Wesselkamper, S. C., Singer, J. B., Hill, A. E., Nadeau, J. H., Leikauf, G. D.
(2008). Reciprocal Congenic Lines of Mice Capture the Aliq1 Effect on Acute Lung Injury Survival Time. Am. J. Respir. Cell Mol. Bio.
38: 68-77
[Abstract][Full Text]
White, K. E., Ding, Q., Moore, B. B., Peters-Golden, M., Ware, L. B., Matthay, M. A., Olman, M. A.
(2008). Prostaglandin E2 Mediates IL-1 -Related Fibroblast Mitogenic Effects in Acute Lung Injury through Differential Utilization of Prostanoid Receptors. J. Immunol.
180: 637-646
[Abstract][Full Text]
Tsuruta, Y., Park, Y.-J., Siegal, G. P., Liu, G., Abraham, E.
(2007). Involvement of Vitronectin in Lipopolysaccaride-Induced Acute Lung Injury. J. Immunol.
179: 7079-7086
[Abstract][Full Text]
Krupa, A., Walencka, M. J., Shrivastava, V., Loyd, T., Fudala, R., Frevert, C. W., Martin, T. R., Kurdowska, A. K.
(2007). Anti-KC Autoantibody:KC Complexes Cause Severe Lung Inflammation in Mice via IgG Receptors. Am. J. Respir. Cell Mol. Bio.
37: 532-543
[Abstract][Full Text]
Villar, J., Perez-Mendez, L., Lopez, J., Belda, J., Blanco, J., Saralegui, I., Suarez-Sipmann, F., Lopez, J., Lubillo, S., Kacmarek, R. M., on behalf of the HELP Network,
(2007). An Early PEEP/FIO2 Trial Identifies Different Degrees of Lung Injury in Patients with Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med.
176: 795-804
[Abstract][Full Text]
Wu, R., Dong, W., Zhou, M., Zhang, F., Marini, C. P., Ravikumar, T. S., Wang, P.
(2007). Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in Rats. Am. J. Respir. Crit. Care Med.
176: 805-813
[Abstract][Full Text]
Netzer, G., Shah, C. V., Iwashyna, T. J., Lanken, P. N., Finkel, B., Fuchs, B., Guo, W., Christie, J. D.
(2007). Association of RBC Transfusion With Mortality in Patients With Acute Lung Injury. Chest
132: 1116-1123
[Abstract][Full Text]
Treggiari, M. M., Martin, D. P., Yanez, N. D., Caldwell, E., Hudson, L. D., Rubenfeld, G. D.
(2007). Effect of Intensive Care Unit Organizational Model and Structure on Outcomes in Patients with Acute Lung Injury. Am. J. Respir. Crit. Care Med.
176: 685-690
[Abstract][Full Text]
Mutlu, G. M., Machado-Aranda, D., Norton, J. E., Bellmeyer, A., Urich, D., Zhou, R., Dean, D. A.
(2007). Electroporation-mediated Gene Transfer of the Na+,K+-ATPase Rescues Endotoxin-induced Lung Injury. Am. J. Respir. Crit. Care Med.
176: 582-590
[Abstract][Full Text]
Malhotra, A.
(2007). Low-Tidal-Volume Ventilation in the Acute Respiratory Distress Syndrome. NEJM
357: 1113-1120
[Full Text]
Cepkova, M., Kapur, V., Ren, X., Quinn, T., Zhuo, H., Foster, E., Liu, K. D., Matthay, M. A.
(2007). Pulmonary Dead Space Fraction and Pulmonary Artery Systolic Pressure as Early Predictors of Clinical Outcome in Acute Lung Injury. Chest
132: 836-842
[Abstract][Full Text]
Leaver, S. K, Evans, T. W
(2007). Acute respiratory distress syndrome. BMJ
335: 389-394
[Full Text]
Prows, D. R., Hafertepen, A. P., Winterberg, A. V., Gibbons, W. J. Jr., Liu, C., Nick, T. G.
(2007). Genetic analysis of hyperoxic acute lung injury survival in reciprocal intercross mice. Physiol. Genomics
30: 271-281
[Abstract][Full Text]
Lee, J. W., Fang, X., Dolganov, G., Fremont, R. D., Bastarache, J. A., Ware, L. B., Matthay, M. A.
(2007). Acute Lung Injury Edema Fluid Decreases Net Fluid Transport across Human Alveolar Epithelial Type II Cells. J. Biol. Chem.
282: 24109-24119
[Abstract][Full Text]
Matute-Bello, G., Wurfel, M. M., Lee, J. S., Park, D. R., Frevert, C. W., Madtes, D. K., Shapiro, S. D., Martin, T. R.
(2007). Essential Role of MMP-12 in Fas-Induced Lung Fibrosis. Am. J. Respir. Cell Mol. Bio.
37: 210-221
[Abstract][Full Text]
Rice, T. W., Wheeler, A. P., Bernard, G. R., Hayden, D. L., Schoenfeld, D. A., Ware, L. B., for the National Institutes of Health, National He,
(2007). Comparison of the SpO2/FIO2 Ratio and the PaO2/FIO2 Ratio in Patients With Acute Lung Injury or ARDS. Chest
132: 410-417
[Abstract][Full Text]
Wang, H. L., Akinci, I. O., Baker, C. M., Urich, D., Bellmeyer, A., Jain, M., Chandel, N. S., Mutlu, G. M., Budinger, G. R. S.
(2007). The Intrinsic Apoptotic Pathway Is Required for Lipopolysaccharide-Induced Lung Endothelial Cell Death. J. Immunol.
179: 1834-1841
[Abstract][Full Text]
Gupta, N., Su, X., Popov, B., Lee, J. W., Serikov, V., Matthay, M. A.
(2007). Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice. J. Immunol.
179: 1855-1863
[Abstract][Full Text]
Nonas, S. A., Vinasco, L. M., Ma, S. F., Jacobson, J. R., Desai, A. A., Dudek, S. M., Flores, C., Hassoun, P. M., Sam, L., Ye, S. Q., Moitra, J., Barnard, J., Grigoryev, D. N., Lussier, Y. A., Garcia, J. G. N.
(2007). Use of consomic rats for genomic insights into ventilator-associated lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol.
293: L292-L302
[Abstract][Full Text]
Fang, W.-F., Cho, J. H., He, Q., Lin, M.-C., Wu, C.-C., Voelkel, N. F., Douglas, I. S.
(2007). Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol.
293: L336-L344
[Abstract][Full Text]
Itoh, T., Obata, H., Murakami, S., Hamada, K., Kangawa, K., Kimura, H., Nagaya, N.
(2007). Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol.
293: L446-L452
[Abstract][Full Text]
Angus, D. C.
(2007). Caring for the Critically Ill Patient: Challenges and Opportunities. JAMA
298: 456-458
[Full Text]
Reutershan, J., Cagnina, R. E., Chang, D., Linden, J., Ley, K.
(2007). Therapeutic Anti-Inflammatory Effects of Myeloid Cell Adenosine Receptor A2a Stimulation in Lipopolysaccharide-Induced Lung Injury. J. Immunol.
179: 1254-1263
[Abstract][Full Text]
Eckle, T., Fullbier, L., Wehrmann, M., Khoury, J., Mittelbronn, M., Ibla, J., Rosenberger, P., Eltzschig, H. K.
(2007). Identification of Ectonucleotidases CD39 and CD73 in Innate Protection during Acute Lung Injury. J. Immunol.
178: 8127-8137
[Abstract][Full Text]
McCarter, S. D., Mei, S. H. J., Lai, P. F. H., Zhang, Q. W., Parker, C. H., Suen, R. S., Hood, R. D., Zhao, Y. D., Deng, Y., Han, R. N. N., Dumont, D. J., Stewart, D. J.
(2007). Cell-based Angiopoietin-1 Gene Therapy for Acute Lung Injury. Am. J. Respir. Crit. Care Med.
175: 1014-1026
[Abstract][Full Text]
Reutershan, J., Stockton, R., Zarbock, A., Sullivan, G. W., Chang, D., Scott, D., Schwartz, M. A., Ley, K.
(2007). Blocking p21-activated Kinase Reduces Lipopolysaccharide-induced Acute Lung Injury by Preventing Polymorphonuclear Leukocyte Infiltration. Am. J. Respir. Crit. Care Med.
175: 1027-1035
[Abstract][Full Text]
Bendtzen, K., Svenson, M., Hansen, M. B., Busch, T., Bercker, S., Kaisers, U., Uchida, K., Beck, D. C., Trapnell, B. C.
(2007). GM-CSF Autoantibodies in Pulmonary Alveolar Proteinosis. NEJM
356: 2001-2002
[Full Text]
Khan, H., Belsher, J., Yilmaz, M., Afessa, B., Winters, J. L., Moore, S. B., Hubmayr, R. D., Gajic, O.
(2007). Fresh-Frozen Plasma and Platelet Transfusions Are Associated With Development of Acute Lung Injury in Critically Ill Medical Patients. Chest
131: 1308-1314
[Abstract][Full Text]
Ferguson, N. D
(2007). Inhaled nitric oxide for acute respiratory distress syndrome. BMJ
334: 757-758
[Full Text]
Wilson, K. R., Napper, J. M., Denvir, J., Sollars, V. E., Yu, H. D.
(2007). Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology
153: 968-979
[Abstract][Full Text]
Bellmeyer, A., Martino, J. M., Chandel, N. S., Scott Budinger, G. R., Dean, D. A., Mutlu, G. M.
(2007). Leptin Resistance Protects Mice from Hyperoxia-induced Acute Lung Injury. Am. J. Respir. Crit. Care Med.
175: 587-594
[Abstract][Full Text]
Memtsoudis, S. G., Rosenberger, P., Walz, J. M.
(2007). Critical Care Issues in the Patient After Major Joint Replacement. J Intensive Care Med
22: 92-104
[Abstract]
Morris, A. E., Stapleton, R. D., Rubenfeld, G. D., Hudson, L. D., Caldwell, E., Steinberg, K. P.
(2007). The Association Between Body Mass Index and Clinical Outcomes in Acute Lung Injury. Chest
131: 342-348
[Abstract][Full Text]
Rubenfeld, G. D., Herridge, M. S.
(2007). Epidemiology and Outcomes of Acute Lung Injury. Chest
131: 554-562
[Abstract][Full Text]
Meyer, N. J., Garcia, J. G. N.
(2007). Wading into the Genomic Pool to Unravel Acute Lung Injury Genetics. Proc Am Thorac Soc
4: 69-76
[Abstract][Full Text]
Perkins, G D, Nathani, N, McAuley, D F, Gao, F, Thickett, D R
(2007). In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax
62: 36-42
[Abstract][Full Text]
Ochs, M.
(2006). Stereological analysis of acute lung injury. ERR
15: 115-121
[Abstract][Full Text]
Christian, M. D., Hawryluck, L., Wax, R. S., Cook, T., Lazar, N. M., Herridge, M. S., Muller, M. P., Gowans, D. R., Fortier, W., Burkle, F. M.
(2006). Development of a triage protocol for critical care during an influenza pandemic.. CMAJ
175: 1377-1381
[Abstract][Full Text]
Wang, X.-Q., Bdeir, K., Yarovoi, S., Cines, D. B., Fang, W., Abraham, E.
(2006). Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury. J. Immunol.
177: 5550-5557
[Abstract][Full Text]
Agarwal, R., Aggarwal, A. N., Gupta, D., Behera, D., Jindal, S. K.
(2006). Etiology and Outcomes of Pulmonary and Extrapulmonary Acute Lung Injury/ARDS in a Respiratory ICU in North India.. Chest
130: 724-729
[Abstract][Full Text]
Cheung, A. M., Tansey, C. M., Tomlinson, G., Diaz-Granados, N., Matte, A., Barr, A., Mehta, S., Mazer, C. D., Guest, C. B., Stewart, T. E., Al-Saidi, F., Cooper, A. B., Cook, D., Slutsky, A. S., Herridge, M. S., for the Canadian Critical Care Trials Group,
(2006). Two-Year Outcomes, Health Care Use, and Costs of Survivors of Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med.
174: 538-544
[Abstract][Full Text]
Kahn, J. M., Goss, C. H., Heagerty, P. J., Kramer, A. A., O'Brien, C. R., Rubenfeld, G. D.
(2006). Hospital volume and the outcomes of mechanical ventilation.. NEJM
355: 41-50
[Abstract][Full Text]
Dulu, A., Pastores, S. M., Park, B., Riedel, E., Rusch, V., Halpern, N. A.
(2006). Prevalence and Mortality of Acute Lung Injury and ARDS After Lung Resection.. Chest
130: 73-78
[Abstract][Full Text]
Medford, A R L, Millar, A B
(2006). Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?. Thorax
61: 621-626
[Abstract][Full Text]
Cepkova, M., Matthay, M. A.
(2006). Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.. J Intensive Care Med
21: 119-143
[Abstract]
Slutsky, A. S., Hudson, L. D.
(2006). PEEP or no PEEP--lung recruitment may be the solution.. NEJM
354: 1839-1841
[Full Text]
Christie, J. D.
(2006). Interleukin-10, age and acute lung injury genetics: the action is in the interaction.. Eur Respir J
27: 669-670
[Full Text]
Matthay, M. A., Abraham, E.
(2006). beta-Adrenergic Agonist Therapy as a Potential Treatment for Acute Lung Injury. Am. J. Respir. Crit. Care Med.
173: 254-255
[Full Text]
Mutlu, G. M., Budinger, G.R. S., Maybauer, M. O., Maybauer, D. M., Herndon, D. N., Rubenfeld, G. D., Caldwell, E., Hudson, L. D.
(2006). Incidence and Outcomes of Acute Lung Injury. NEJM
354: 416-417
[Full Text]
Camporota, L
(2006). The public health burden of acute lung injury. Thorax
61: 56-56
[Full Text]
Tonks, A.
(2005). What's new in the other general journals. BMJ
331: 987-988
[Full Text]
(2005). Profile of Acute Lung Injury and ARDS. JWatch General
2005: 6-6
[Full Text]
Herridge, M. S., Angus, D. C.
(2005). Acute lung injury--affecting many lives.. NEJM
353: 1736-1738
[Full Text]